1. Acute pain related to the disease process and drug-induced joint pain, stomatitis, GI distress, and other discomforts associated with antineoplastic cell cycle–specific therapy 2. Risk for...

1. Acute pain related to the disease process and drug-induced joint pain, stomatitis, GI distress, and other discomforts associated with antineoplastic cell cycle–specific therapy

2. Risk for infection related to drug-induced bone marrow suppression with possible leukopenia and neutropenia